SlideShare ist ein Scribd-Unternehmen logo
1 von 15
Jan Geissler – EUPATI Director
jan@patientsacademy.eu
Education of
patients (advocates) on R&D:
European Patients’ Academy
on Therapeutic Innovation
The project is receiving support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115334, resources of which are composed
of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.
Patients
should be at the center
of any health research.
But why and how?
Medical landscape is changing
at a fast pace
Innovation transforms the lives of
patients with serious, lifelong conditions:
 Molecular targets/pathways
 Genome sequencing,
 Translational research
 Personalized medicine
• Small trial populations
• Biomarkers, companion diagnostics
 Need for post-marketing data
 Health Technology Assessment,
QoL, endpoints, comparators
 BUT long term pressure on health budgets
– here to stay
Window of
opportunity
 trial design
 relationship
between
researchers,
regulators,
industry,
patients
3
Patients – as key partners of researchers
More needs to be done: rare cancers will never be a priority unless
the patients make it one. Patients themselves must therefore
play a larger role in driving forward the search for therapies.
They are able to see connections that have eluded scientists.
“ „
Unique examples of patient involvement in
R&D and regulatory affairs already today
Patients' and Consumers' Working Party
Patient advocates’ key role in building
new environment for R&D
 Patient organisations have unique insights
into „real life“ and „real needs“ of patients:
• Gaps  research priorities
• Clinical trial design
• Quality of Life, Side effects
• Real-world access to therapies
• „Value“
• Patient-centered research policy
PatientPartner FP7 Project (2010),
www.patientpartner-europe.eu
Research subject
Info provider
Advisor
Reviewer
Co-researcher
Driving force
Public
Research Ethics
Committees
Competent
authorities
Policy makers
/Research Policy
HTA agencies
& committees
Research subject
Info provider
Advisor
Reviewer
Co-researcher
Driving force
Clinical
Research
Patients have a key role in all aspects of
health-related research
Trial protocol design,
informed consent, ethical
review, marketing
authorization, value
assessment, health policy
European Patients’ Academy: Paradigm shift
in empowering patients on medicines R&D
 Launched Feb ’12, runs for 5 years,
30 consortium members,
Funded by IMI JU
 will develop and disseminate
objective, credible,
correct and up-to-date public
knowledge about medicines
R&D
 will build competencies
& expert capacity among patients & public
 will facilitate patient involvement in R&D to collaborate in academic
research, industry research, authorities and ethics committees
Project led by 4 key pan-European
patient associations
◦ EUPATI Project Coordination
◦ >50 umbrella patient
organisations.
◦ Linking national and regional
patient alliances
◦ >600 rare disease
organisations in
>45 countries
◦ >100 members in over 30
countries
Areas covered by the
European Patients’ Academy
1. Discovery of Medicines & Planning of Medicines Development
2. Non-Clinical Testing and Pharmaceutical Development
3. Exploratory and Confirmatory Clinical Development
4. Clinical Trials
5. Regulatory Affairs, Medicinal product Safety, Pharmacovigilance
and Pharmaco-epidemiology
6. Health Technology Assessment and the
economics
…and NOT:
develop indication-
or therapy-specific
information!
EUPATI Internet Library
EUPATI Educational Toolbox
EUPATI Training Programme
To bring this to life, EUPATI develops
education targeted at different levels
100
“expert”
patient
advocates
12.000
patient
advocates
100.000
individuals
AT
BE
CH
DE
ES
FR
IT
IE
LU
MT
PL
UK
EUPATI Blended Learning
“Expert Patient” Training Course
 In-depth course for patient advocates to be able to contribute to
medicines R&D in academic groups, industry, competent authorities
(EMA & national), research policy etc.
 Course recruitment has opened on 6 March 2014,
closing date 20 April 2014, start of course Sept 2014
 Apply at www.patientsacademy.eu/apply
e-Learning
EUPATI Training Programme
9/2014 – 9/2015
Application
Phase
3-4/2014
e-Learning f2f e-Learning f2f
Certificate
Internet Library
Toolbox
Courses
Next steps
 EUPATI Public Workshop 2014
“Reaching a Public Audience on
Medicines Development”, 2 April 2014,
Warsaw
 Start of EUPATI Course
apply until 20 April 2014!
13
To address unmet needs
and make research more patient-centric,
(more) patient advocates need
to be involved as partners.
EUPATI helps
to make that happen.
Thank you!
Web:
www.patientsacademy.eu
Twitter: @eupatients
as well as:

Weitere ähnliche Inhalte

Was ist angesagt?

EUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvement
EUPATI
 
How to raise interest in medicines development: Results from Workgroup 1
How to raise interest in medicines development: Results from Workgroup 1How to raise interest in medicines development: Results from Workgroup 1
How to raise interest in medicines development: Results from Workgroup 1
Nowgen
 
IMI Graham Hughes
IMI Graham HughesIMI Graham Hughes
IMI Graham Hughes
CK Group
 

Was ist angesagt? (20)

Derick mitchell, IPPOSI
Derick mitchell, IPPOSIDerick mitchell, IPPOSI
Derick mitchell, IPPOSI
 
EUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvementEUPATI patient expert training course and its relevance for patient involvement
EUPATI patient expert training course and its relevance for patient involvement
 
Future Health Summit - Dr Derick Mitchell - May 26th 2016
Future Health Summit - Dr Derick Mitchell - May 26th 2016Future Health Summit - Dr Derick Mitchell - May 26th 2016
Future Health Summit - Dr Derick Mitchell - May 26th 2016
 
Jornadas #PatientInHTA · Jesús González
Jornadas #PatientInHTA · Jesús GonzálezJornadas #PatientInHTA · Jesús González
Jornadas #PatientInHTA · Jesús González
 
Jornadas #PatientInHTA · Ana Toledo
Jornadas #PatientInHTA · Ana ToledoJornadas #PatientInHTA · Ana Toledo
Jornadas #PatientInHTA · Ana Toledo
 
G1 report from breakout group 1
G1 report from breakout group 1G1 report from breakout group 1
G1 report from breakout group 1
 
Introduction to the workshop and EUPATI update
Introduction to the workshop and EUPATI updateIntroduction to the workshop and EUPATI update
Introduction to the workshop and EUPATI update
 
G2 report from breakout group 2
G2 report from breakout group 2G2 report from breakout group 2
G2 report from breakout group 2
 
Reaching a public audience on medicines development: Anna Zawada
Reaching a public audience on medicines development: Anna ZawadaReaching a public audience on medicines development: Anna Zawada
Reaching a public audience on medicines development: Anna Zawada
 
What were the success factors in this morning good practices examples, what a...
What were the success factors in this morning good practices examples, what a...What were the success factors in this morning good practices examples, what a...
What were the success factors in this morning good practices examples, what a...
 
Croi Galway - Derick Mitchell - July 2016
Croi Galway - Derick Mitchell - July 2016Croi Galway - Derick Mitchell - July 2016
Croi Galway - Derick Mitchell - July 2016
 
Webinar: Guidance on Industry-led R&D
Webinar: Guidance on Industry-led R&DWebinar: Guidance on Industry-led R&D
Webinar: Guidance on Industry-led R&D
 
How to raise interest in medicines development: Results from Workgroup 1
How to raise interest in medicines development: Results from Workgroup 1How to raise interest in medicines development: Results from Workgroup 1
How to raise interest in medicines development: Results from Workgroup 1
 
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
 
Patients’ voice in access decisions
Patients’ voice in access decisionsPatients’ voice in access decisions
Patients’ voice in access decisions
 
European Patients Academy - Presentation of Jan Geissler at EPF AGM
European Patients Academy - Presentation of  Jan Geissler at EPF AGMEuropean Patients Academy - Presentation of  Jan Geissler at EPF AGM
European Patients Academy - Presentation of Jan Geissler at EPF AGM
 
IMI Graham Hughes
IMI Graham HughesIMI Graham Hughes
IMI Graham Hughes
 
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
 
How to communicate scientific and medical information to patients, advocates ...
How to communicate scientific and medical information to patients, advocates ...How to communicate scientific and medical information to patients, advocates ...
How to communicate scientific and medical information to patients, advocates ...
 
Research managers jan 14th, 2016 - ipposi presentation
Research managers   jan 14th, 2016 - ipposi presentationResearch managers   jan 14th, 2016 - ipposi presentation
Research managers jan 14th, 2016 - ipposi presentation
 

Ähnlich wie Education of patients (advocates) on R&D: European Patients’ Academy EUPATI (Jan Geissler)

Presentation for EPEMED Webinar (11-27-12) Final
Presentation for EPEMED Webinar (11-27-12) FinalPresentation for EPEMED Webinar (11-27-12) Final
Presentation for EPEMED Webinar (11-27-12) Final
Stig Albinus
 

Ähnlich wie Education of patients (advocates) on R&D: European Patients’ Academy EUPATI (Jan Geissler) (20)

Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
 
EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...EUPATI’s framework on Informing the “health-interested” public about medicine...
EUPATI’s framework on Informing the “health-interested” public about medicine...
 
European Patients’ Academy on Therapeutic Innovation: Shifting paradigms in ...
European Patients’ Academy on Therapeutic Innovation:Shifting paradigms in ...European Patients’ Academy on Therapeutic Innovation:Shifting paradigms in ...
European Patients’ Academy on Therapeutic Innovation: Shifting paradigms in ...
 
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the InternetJan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internet
 
The emergence of the e-patient
The emergence of the e-patientThe emergence of the e-patient
The emergence of the e-patient
 
Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...Tripartite dimension of interaction of patients, regulators and industry (Jan...
Tripartite dimension of interaction of patients, regulators and industry (Jan...
 
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
EUPATI – EU: An overview (Eibhlin Mulroe, EUPATI / IPPOSI)
 
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
A snapshot of EUPATI: Why the educated patient is so vital to success in clin...
 
Partnering with Patients: Designing, Participating in and Reporting Health Ou...
Partnering with Patients: Designing, Participating in and Reporting Health Ou...Partnering with Patients: Designing, Participating in and Reporting Health Ou...
Partnering with Patients: Designing, Participating in and Reporting Health Ou...
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
 
The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...
 
Presentation for EPEMED Webinar (11-27-12) Final
Presentation for EPEMED Webinar (11-27-12) FinalPresentation for EPEMED Webinar (11-27-12) Final
Presentation for EPEMED Webinar (11-27-12) Final
 
UCD PharmTox event on Clinical Trials
UCD PharmTox event on Clinical TrialsUCD PharmTox event on Clinical Trials
UCD PharmTox event on Clinical Trials
 
Alpha One Conference - IPPOSI
Alpha One Conference - IPPOSIAlpha One Conference - IPPOSI
Alpha One Conference - IPPOSI
 
Changes in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical worldChanges in patient organisations - and how this changes the medical world
Changes in patient organisations - and how this changes the medical world
 
CHESS Connected Health training network - Derick Mitchell - August 2016
CHESS Connected Health training network - Derick Mitchell - August 2016CHESS Connected Health training network - Derick Mitchell - August 2016
CHESS Connected Health training network - Derick Mitchell - August 2016
 
Pharmacovigilance: Partnering for Patient Safety
Pharmacovigilance: Partnering for Patient SafetyPharmacovigilance: Partnering for Patient Safety
Pharmacovigilance: Partnering for Patient Safety
 
Pistoia Alliance European Conference 2015 - Ann Martin / IMI
Pistoia Alliance European Conference 2015 - Ann Martin / IMIPistoia Alliance European Conference 2015 - Ann Martin / IMI
Pistoia Alliance European Conference 2015 - Ann Martin / IMI
 
Prostate cancer nov 11, 2015
Prostate cancer   nov 11, 2015Prostate cancer   nov 11, 2015
Prostate cancer nov 11, 2015
 
What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...What do people think about medicines research and development? (Starling, EUP...
What do people think about medicines research and development? (Starling, EUP...
 

Mehr von jangeissler

Mehr von jangeissler (20)

Relevanz von Laienzusammenfassungen von Studienergebnissen für Patienten
Relevanz von Laienzusammenfassungen von Studienergebnissen für Patienten Relevanz von Laienzusammenfassungen von Studienergebnissen für Patienten
Relevanz von Laienzusammenfassungen von Studienergebnissen für Patienten
 
Don't just talk about patient centricity - put meaningful patient engagement ...
Don't just talk about patient centricity - put meaningful patient engagement ...Don't just talk about patient centricity - put meaningful patient engagement ...
Don't just talk about patient centricity - put meaningful patient engagement ...
 
CML: A tiger in the cage? A (European) perspective on CML disease management
CML: A tiger in the cage? A (European) perspective on CML disease managementCML: A tiger in the cage? A (European) perspective on CML disease management
CML: A tiger in the cage? A (European) perspective on CML disease management
 
Sicht der Patienten auf Real World Data, Register und Versorgungsdaten
Sicht der Patienten auf Real World Data, Register und VersorgungsdatenSicht der Patienten auf Real World Data, Register und Versorgungsdaten
Sicht der Patienten auf Real World Data, Register und Versorgungsdaten
 
Überblick der Aktivitäten von Leukämie-Online und CML Advocates Network
Überblick der Aktivitäten von Leukämie-Online und CML Advocates NetworkÜberblick der Aktivitäten von Leukämie-Online und CML Advocates Network
Überblick der Aktivitäten von Leukämie-Online und CML Advocates Network
 
Andreas Willer - Rehabilitation für Patienten mit CML
Andreas Willer - Rehabilitation für Patienten mit CMLAndreas Willer - Rehabilitation für Patienten mit CML
Andreas Willer - Rehabilitation für Patienten mit CML
 
Umfrage zur Therapiefreien Remission (TFR) der CML-Patientengemeinschaft
Umfrage zur Therapiefreien Remission (TFR) der CML-PatientengemeinschaftUmfrage zur Therapiefreien Remission (TFR) der CML-Patientengemeinschaft
Umfrage zur Therapiefreien Remission (TFR) der CML-Patientengemeinschaft
 
Patientenperspektive im Studiendesign
Patientenperspektive im Studiendesign Patientenperspektive im Studiendesign
Patientenperspektive im Studiendesign
 
Reasonable Legal Agreements between Patient Advocates and Pharma Companies
Reasonable Legal Agreements between Patient Advocates and Pharma CompaniesReasonable Legal Agreements between Patient Advocates and Pharma Companies
Reasonable Legal Agreements between Patient Advocates and Pharma Companies
 
Bericht LeukaNET / leukaemie-online.de und CML Advocates Network
Bericht LeukaNET / leukaemie-online.de und CML Advocates NetworkBericht LeukaNET / leukaemie-online.de und CML Advocates Network
Bericht LeukaNET / leukaemie-online.de und CML Advocates Network
 
How to get the most of the EHA congress as a CML patient advocate
How to get the most of the EHA congress as a CML patient advocateHow to get the most of the EHA congress as a CML patient advocate
How to get the most of the EHA congress as a CML patient advocate
 
European Patient Perspective on Access and Innovation with Multiplex Genomic ...
European Patient Perspective on Access and Innovation with Multiplex Genomic ...European Patient Perspective on Access and Innovation with Multiplex Genomic ...
European Patient Perspective on Access and Innovation with Multiplex Genomic ...
 
European Cancer Patient Advocacy: Introduction to the community, key stakehol...
European Cancer Patient Advocacy: Introduction to the community, key stakehol...European Cancer Patient Advocacy: Introduction to the community, key stakehol...
European Cancer Patient Advocacy: Introduction to the community, key stakehol...
 
Häufige Fragen von CML-Patienten und Welt-CML-Tag 2017
Häufige Fragen von CML-Patienten und Welt-CML-Tag 2017Häufige Fragen von CML-Patienten und Welt-CML-Tag 2017
Häufige Fragen von CML-Patienten und Welt-CML-Tag 2017
 
CML: What's New at EHA? Tim Brümmendorf, EHA Capacity Building Session, EHA c...
CML: What's New at EHA? Tim Brümmendorf, EHA Capacity Building Session, EHA c...CML: What's New at EHA? Tim Brümmendorf, EHA Capacity Building Session, EHA c...
CML: What's New at EHA? Tim Brümmendorf, EHA Capacity Building Session, EHA c...
 
How to get the most of EHA as a patient advocate
How to get the most of EHA as a patient advocateHow to get the most of EHA as a patient advocate
How to get the most of EHA as a patient advocate
 
PCR-Info-Projekt (Cornelia Borowczak)
PCR-Info-Projekt (Cornelia Borowczak)PCR-Info-Projekt (Cornelia Borowczak)
PCR-Info-Projekt (Cornelia Borowczak)
 
The Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacyThe Networked Patient Group: How technology changes the face of patient advocacy
The Networked Patient Group: How technology changes the face of patient advocacy
 
Similarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare DiseasesSimilarities and differences between Rare Cancers and Rare Diseases
Similarities and differences between Rare Cancers and Rare Diseases
 
The role of patients and healthcare providers in translational medicine
The role of patients and healthcare providers in translational medicineThe role of patients and healthcare providers in translational medicine
The role of patients and healthcare providers in translational medicine
 

Kürzlich hochgeladen

🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
Call Girls In Delhi Whatsup 9873940964 Enjoy Unlimited Pleasure
 

Kürzlich hochgeladen (20)

Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
 
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated  Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...Top Rated  Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 9332606886 ⟟ Call Me For Genuine ...
 
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
Call Girls Service Jaipur {9521753030} ❤️VVIP RIDDHI Call Girl in Jaipur Raja...
 
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
 
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Ahmedabad Just Call 9630942363 Top Class Call Girl Service Available
 
Call Girls Raipur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Raipur Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Raipur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Raipur Just Call 9630942363 Top Class Call Girl Service Available
 
Top Rated Bangalore Call Girls Richmond Circle ⟟ 9332606886 ⟟ Call Me For Ge...
Top Rated Bangalore Call Girls Richmond Circle ⟟  9332606886 ⟟ Call Me For Ge...Top Rated Bangalore Call Girls Richmond Circle ⟟  9332606886 ⟟ Call Me For Ge...
Top Rated Bangalore Call Girls Richmond Circle ⟟ 9332606886 ⟟ Call Me For Ge...
 
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service AvailableCall Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
 
O898O367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
O898O367676 Call Girls In Ahmedabad Escort Service Available 24×7 In AhmedabadO898O367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
O898O367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
 
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
 
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
 
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
 
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
 
Call Girls Guntur Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Guntur  Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Guntur  Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Guntur Just Call 8250077686 Top Class Call Girl Service Available
 
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
 
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
 
Call Girls Shimla Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Shimla Just Call 8617370543 Top Class Call Girl Service AvailableCall Girls Shimla Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Shimla Just Call 8617370543 Top Class Call Girl Service Available
 
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
 
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
VIP Hyderabad Call Girls Bahadurpally 7877925207 ₹5000 To 25K With AC Room 💚😋
 

Education of patients (advocates) on R&D: European Patients’ Academy EUPATI (Jan Geissler)

  • 1. Jan Geissler – EUPATI Director jan@patientsacademy.eu Education of patients (advocates) on R&D: European Patients’ Academy on Therapeutic Innovation The project is receiving support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115334, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.
  • 2. Patients should be at the center of any health research. But why and how?
  • 3. Medical landscape is changing at a fast pace Innovation transforms the lives of patients with serious, lifelong conditions:  Molecular targets/pathways  Genome sequencing,  Translational research  Personalized medicine • Small trial populations • Biomarkers, companion diagnostics  Need for post-marketing data  Health Technology Assessment, QoL, endpoints, comparators  BUT long term pressure on health budgets – here to stay Window of opportunity  trial design  relationship between researchers, regulators, industry, patients 3
  • 4. Patients – as key partners of researchers More needs to be done: rare cancers will never be a priority unless the patients make it one. Patients themselves must therefore play a larger role in driving forward the search for therapies. They are able to see connections that have eluded scientists. “ „
  • 5. Unique examples of patient involvement in R&D and regulatory affairs already today Patients' and Consumers' Working Party
  • 6. Patient advocates’ key role in building new environment for R&D  Patient organisations have unique insights into „real life“ and „real needs“ of patients: • Gaps  research priorities • Clinical trial design • Quality of Life, Side effects • Real-world access to therapies • „Value“ • Patient-centered research policy PatientPartner FP7 Project (2010), www.patientpartner-europe.eu Research subject Info provider Advisor Reviewer Co-researcher Driving force
  • 7. Public Research Ethics Committees Competent authorities Policy makers /Research Policy HTA agencies & committees Research subject Info provider Advisor Reviewer Co-researcher Driving force Clinical Research Patients have a key role in all aspects of health-related research Trial protocol design, informed consent, ethical review, marketing authorization, value assessment, health policy
  • 8. European Patients’ Academy: Paradigm shift in empowering patients on medicines R&D  Launched Feb ’12, runs for 5 years, 30 consortium members, Funded by IMI JU  will develop and disseminate objective, credible, correct and up-to-date public knowledge about medicines R&D  will build competencies & expert capacity among patients & public  will facilitate patient involvement in R&D to collaborate in academic research, industry research, authorities and ethics committees
  • 9. Project led by 4 key pan-European patient associations ◦ EUPATI Project Coordination ◦ >50 umbrella patient organisations. ◦ Linking national and regional patient alliances ◦ >600 rare disease organisations in >45 countries ◦ >100 members in over 30 countries
  • 10. Areas covered by the European Patients’ Academy 1. Discovery of Medicines & Planning of Medicines Development 2. Non-Clinical Testing and Pharmaceutical Development 3. Exploratory and Confirmatory Clinical Development 4. Clinical Trials 5. Regulatory Affairs, Medicinal product Safety, Pharmacovigilance and Pharmaco-epidemiology 6. Health Technology Assessment and the economics …and NOT: develop indication- or therapy-specific information!
  • 11. EUPATI Internet Library EUPATI Educational Toolbox EUPATI Training Programme To bring this to life, EUPATI develops education targeted at different levels 100 “expert” patient advocates 12.000 patient advocates 100.000 individuals AT BE CH DE ES FR IT IE LU MT PL UK
  • 12. EUPATI Blended Learning “Expert Patient” Training Course  In-depth course for patient advocates to be able to contribute to medicines R&D in academic groups, industry, competent authorities (EMA & national), research policy etc.  Course recruitment has opened on 6 March 2014, closing date 20 April 2014, start of course Sept 2014  Apply at www.patientsacademy.eu/apply e-Learning EUPATI Training Programme 9/2014 – 9/2015 Application Phase 3-4/2014 e-Learning f2f e-Learning f2f Certificate Internet Library Toolbox Courses
  • 13. Next steps  EUPATI Public Workshop 2014 “Reaching a Public Audience on Medicines Development”, 2 April 2014, Warsaw  Start of EUPATI Course apply until 20 April 2014! 13
  • 14. To address unmet needs and make research more patient-centric, (more) patient advocates need to be involved as partners. EUPATI helps to make that happen.